Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
EV/Core EBITDA

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 31.620.220.78-0.10

What is the latest EV/Core EBITDA ratio of CORONA REMEDIES ?

The latest EV/Core EBITDA ratio of CORONA REMEDIES is 31.62 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202631.62
Mar20250.22
Mar20240.78
Mar2023-0.10

How is EV/Core EBITDA of CORONA REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2026 31.62
14,272.73
Mar2025 0.22
-71.79
Mar2024 0.78
Positive
Mar2023 -0.1 -

Other Financial Ratios of CORONA REMEDIES


Compare EV/Core EBITDA ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,384.7 Cr -0.8% -8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -0.8% -5.1% 6.3% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -3.2% -1.4% 53.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -1.6% -6% 32.1% Stock Analytics
CIPLA ₹107,447.0 Cr 0% -3.6% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 3.1% 8.7% -1.5% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.8%

-8%

NA
SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses